Logo image
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
Journal article   Open access   Peer reviewed

Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism

Samuel N Rodman, Jacquelyn M Spence, Tyler J Ronnfeldt, Yueming Zhu, Shane R Solst, Rebecca A O'Neill, Bryan G Allen, Xiangming Guan, Douglas R Spitz and Melissa A Fath
Radiation research, Vol.186(4), pp.385-395
10/2016
DOI: 10.1667/RR14463.1
PMCID: PMC5077643
PMID: 27643875
url
http://doi.org/10.1667/RR14463.1View
Open Access

Abstract

The goal of this study was to determine if depletion of glutathione (GSH) and inhibition of thioredoxin (Trx) reductase (TrxR) activity could enhance radiation responses in human breast cancer stem cells by a mechanism involving thiol-dependent oxidative stress. The following were used to inhibit GSH and Trx metabolism: buthionine sulfoximine (BSO), a GSH synthesis inhibitor; sulfasalazine (SSZ), an inhibitor of x cysteine/glutamate antiporter; auranofin (Au), a thioredoxin reductase inhibitor; or 2-AAPA, a GSH-reductase inhibitor. Clonogenic survival, Matrigel assays, flow cytometry cancer stem cell assays (CD44 CD24 ESA or ALDH1) and human tumor xenograft models were used to determine the antitumor activity of drug and radiation combinations. Combined inhibition of GSH and Trx metabolism enhanced cancer cell clonogenic killing and radiation responses in human breast and pancreatic cancer cells via a mechanism that could be inhibited by N-acetylcysteine (NAC). Au, BSO and radiation also significantly decreased breast cancer cell migration and invasion in a thiol-dependent manner that could be inhibited by NAC. In addition, pretreating cells with Au sensitized breast cancer stem cell populations to radiation in vitro as determined by CD44 CD24 ESA or ALDH1. Combined administration of Au and BSO, given prior to irradiation, significantly increased the survival of mice with human breast cancer xenografts, and decreased the number of ALDH1 cancer stem cells. These results indicate that combined inhibition of GSH- and Trx-dependent thiol metabolism using pharmacologically relevant agents can enhance responses of human breast cancer stem cells to radiation both in vitro and in vivo.
Buthionine Sulfoximine - pharmacology Glutathione - metabolism Neoplastic Stem Cells - drug effects Humans Sulfasalazine - pharmacology Glutathione - biosynthesis Drug Interactions Thiocarbamates - pharmacology Neoplastic Stem Cells - metabolism Acetylcysteine - analogs & derivatives Neoplastic Stem Cells - pathology Female Thioredoxins - metabolism Neoplastic Stem Cells - radiation effects Auranofin - pharmacology Cell Survival - drug effects Neoplasm Invasiveness Radiation-Sensitizing Agents - pharmacology Cell Survival - radiation effects Cell Movement - radiation effects Cell Movement - drug effects Animals Breast Neoplasms - pathology Cell Transformation, Neoplastic Acetylcysteine - pharmacology Survival Analysis Cell Line, Tumor Mice Thioredoxin-Disulfide Reductase - antagonists & inhibitors DNA Damage

Details

Metrics

Logo image